A Trial of Rehabilitation Paired with VNS for Motor Function in Patients with Stroke (Repair Study)

Last updated: December 9, 2024
Sponsor: Beijing Pins Medical Co., Ltd
Overall Status: Active - Recruiting

Phase

N/A

Condition

Occlusions

Polymyositis (Inflammatory Muscle Disease)

Blood Clots

Treatment

VNS

Sham VNS

Rehabilitation

Clinical Study ID

NCT06722677
G115R&PINS-C2-01-53
  • Ages 22-80
  • All Genders

Study Summary

The goal of this clinical trial is to investigate the efficacy and safety of vagus nerve stimulation (VNS) paired with rehabilitation for enhancing upper extremity motor function after ischemic stroke.

Researchers will compare the outcomes of active VNS paired with rehabilitation against sham VNS (the actual intensity is 0 mA) also paired with rehabilitation, in order to assess improvements in arm motor function post-stroke.

Participants in this study will undergo a surgical procedure to implant the VNS system and will subsequently recieve a 6 weeks in-clinic therapy, followed by an additional 6 weeks home exercise. During the final 6 weeks, participants will either recieve in-clinic therapy or maintain their home exercise, depending on their assigned group.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Age ≥22 years and <80 years, all gender is acceptable.

  2. History of unilateral supratentorial ischemic stroke ≥ 9 months but < 10 years.

  3. Upper Extremity motor section of the Fugl-Meyer Assessment score ≥20 and ≤50.

  4. Right- or left-sided weakness of upper extremity.

  5. Ability to communicate, understand, and give appropriate consent. Subjects canfollow trial commands.

  6. Subjects have good compliance and can complete the visits after surgery.

Exclusion

Exclusion Criteria:

  1. History of hemorrhagic stroke.

  2. Presence of ongoing dysphagia or aspiration difficulties.

  3. Prior injury to vagus nerve, either bilateral or unilateral.

  4. Subject receiving medication that may significantly interfere with actions of VNS onneurotransmitter systems at study entry, clinic rehabilitation follow-up timepoint,or home rehabilitation follow-up timepoint, such as centrally acting cholinoceptorblockers, centrally acting adrenoceptor blockers, norepinephrine re-uptakeinhibitors, etc.

  5. Botox injections within 4 weeks prior to enrollment through the unmasking follow-uptimepoint (Visit 6).

  6. Severe spasticity of the upper extremity (Modified Ashworth ≥ 3).

  7. Significant sensory loss of the upper extremity (Upper Extremity sensory section ofthe Fugl-Meyer Assessment score < 6).

  8. Severe depression (Beck Depression Scale > 29).

  9. Current requirement, or likely future requirement, of diathermy.

  10. Current use of any other stimulation device, such as a pacemaker or otherneurostimulator.

  11. Pregnancy or plans to become pregnant or to breastfeed during the study period.

  12. Participated in any other clinical trials within the preceding 3 months.

  13. Not considered to be applicable by the investigator.

Study Design

Total Participants: 99
Treatment Group(s): 3
Primary Treatment: VNS
Phase:
Study Start date:
November 19, 2024
Estimated Completion Date:
November 30, 2025

Study Description

There are 6 follow-up timepoints in this trial:

  1. Screening follow-up timepoint (V1): All participants will sign the informed consent form and receive pre-implant evaluation, including physical examination, brain magnetic resonance imaging, FMA-UE, WMFT, modified Ashworth sacle, BDI, ect.

  2. Surgery follow-up timepoint (V2):All participants will be implanted with the VNS system, including the G115R IPG and L312 lead.

  3. Baseline follow-up timepoint (V3): There is a baseline evaluation 7 to 14 days after the surgery, then participants will be randomly assigned to VNS group or Control group. The randomization will be stratified by baseline FMA-UE (20 to 35, 36 to 50), age (<50, ≥50) and research center (south centers, north centers).

  4. Clinic rehabilitation follow-up timepoint (V4): Participants will receive standard clinic rehabilitation 3 days per week and lasting 6 weeks. Active VNS (VNS group) or sham VNS (Control group) will be paired with rehabilitation. Participants will be evaluated at the last day of this follow-up timepoint.

  5. Home exercise follow-up timepoint (V5): Participants will take standard home exercise everyday in 6 weeks. Active VNS (VNS group) or sham VNS (Control group) will be paired with rehabilitation. At the last day, after evaluating, group assignment is unblinded.

  6. Unmasking follow-up timepoint (V6): In this 6 weeks, all participants will receive active VNS. Participants in VNS group will still take standard home exercise, and participants in Control group will receive standard clinic rehabilitation again. Participants will be also evaluated at the last day of this follow-up timepoint.

Connect with a study center

  • The First Affiliated Hospital of USTC

    Hefei, Anhui 230022
    China

    Site Not Available

  • Beijing Tiantan Hospital, Capital Medical University

    Beijing, Beijing 100000
    China

    Active - Recruiting

  • Chinese People's Liberation Army General Hospital

    Beijing, Beijing 100039
    China

    Site Not Available

  • The Xin Qiao Hospital of Army Medical University

    Chongqing, Chongqing 400037
    China

    Site Not Available

  • The First Affiliated Hospital of Fujian Medical University

    Fuzhou, Fujian 350004
    China

    Active - Recruiting

  • Zhujiang Hospital of Southern Medical University

    Guangzhou, Guangdong 510260
    China

    Active - Recruiting

  • Jiangbin Hospital of Guangxi Zhuang Autonomous Region

    Nanning, Guangxi 530012
    China

    Active - Recruiting

  • Tongji Hospital Tongji Medical College of HUST

    Wuhan, Hubei 430030
    China

    Active - Recruiting

  • Brain Hospital of Hunan Province The Second People's Hospital of Hunan Province

    Changsha, Hunan 410000
    China

    Site Not Available

  • Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing university Medical School

    Nanjing, Jiangsu 210008
    China

    Site Not Available

  • The First Affiliated Hospital of Nanchang University

    Nanchang, Jiangxi 330006
    China

    Site Not Available

  • The First Bethune Hospital of Jilin University

    Changchun, Jilin 130021
    China

    Active - Recruiting

  • Qilu Hospital of Shandong University

    Jinan, Shandong 250012
    China

    Site Not Available

  • Huashan Hospital, Fudan University

    Shanghai, Shanghai 200040
    China

    Active - Recruiting

  • West China Hospital, Sichuan University

    Chengdu, Sichuan 618099
    China

    Site Not Available

  • The First Affiliated Hospital of Kunming Medical University

    Kunming, Yunnan 650032
    China

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.